NICE TAs

11/08/2020

TA386: Ruxolitinib for treating disease-related splenomegaly or symptoms in adults with myelofibrosis (replaced TA289)

10/08/2020

TA421: Everolimus with exemestane for treating advanced breast cancer after endocrine therapy (replaced TA295)

10/08/2020

TA285: Bevacizumab in combination with gemcitabine and carboplatin for treating the first recurrence of platinum-sensitive advanced ovarian cancer

10/08/2020

TA290: Mirabegron for treating symptoms of overactive bladder

10/08/2020

TA337: Rifaximin for preventing episodes of overt hepatic encephalopathy

05/08/2020

TA333: Axitinib for treating advanced renal cell carcinoma after failure of prior systemic treatment

05/08/2020

TA294: Aflibercept solution for injection for treating wet age‑related macular degeneration

05/08/2020

TA287: Rivaroxaban for treating pulmonary embolism and preventing recurrent venous thromboembolism

05/08/2020

TA275: Apixaban for preventing stroke and systemic embolism in people with nonvalvular atrial fibrillation

05/08/2020

TA422: Crizotinib for previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer (replaced TA296)

05/08/2020

TA640: Treosulfan with fludarabine for malignant disease before allogeneic stem cell transplant

05/08/2020

TA300: Peginterferon alfa and ribavirin for treating chronic hepatitis C in children and young people

05/08/2020

TA292: Aripiprazole for treating moderate to severe manic episodes in adolescents with bipolar I disorder

05/08/2020

TA509:Pertuzumab with trastuzumab and docetaxel for treating HER2-positive breast cancer

05/08/2020

TA316: Enzalutamide for metastatic hormone‑relapsed prostate cancer previously treated with a docetaxel‑containing regimen

05/08/2020

TA297: Ocriplasmin for treating vitreomacular traction

29/07/2020

TA308: Rituximab in combination with glucocorticoids for treating anti-neutrophil cytoplasmic antibody-associated vasculitis

29/07/2020

TA303: Teriflunomide for treating relapsing–remitting multiple sclerosis

29/07/2020

TA320: Dimethyl fumarate for treating relapsing‑remitting multiple sclerosis

29/07/2020

TA322: Lenalidomide for treating myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality